Cargando…
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
BACKGROUND: Immune checkpoints target regulatory pathways in T cells that enhance antitumor immune responses and elicit durable clinical responses. As a novel immune checkpoint, CD96 is an attractive key target for cancer immunotherapy. However, there has been no integrative investigation of CD96 in...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338376/ https://www.ncbi.nlm.nih.gov/pubmed/32695752 http://dx.doi.org/10.3389/fbioe.2020.00592 |